Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 31;11(8):927.
doi: 10.3390/children11080927.

Comparison of Single-Treatment Efficacy of Bevacizumab and Ranibizumab for Retinopathy of Prematurity

Fumio Takano  1 , Kaori Ueda  1 , Yuko Yamada-Nakanishi  1 , Makoto Nakamura  1
Affiliations

Comparison of Single-Treatment Efficacy of Bevacizumab and Ranibizumab for Retinopathy of Prematurity

Fumio Takano et al. Children (Basel). .

Abstract

Background: Retinopathy of prematurity (ROP) is a significant cause of blindness in infants. Appropriate therapeutic intervention is essential because retinal detachment due to the progression of ROP is critical to visual function. The intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents has been increasingly applied to inhibit the development and progression of ROP. In this study, we compared the efficacy of single intravitreal bevacizumab (IVB) and ranibizumab (IVR) injections for the treatment of ROP.

Methods: A total of 39 eyes in 21 patients with severe ROP and IVB (15 eyes of 8 patients) and IVR (24 eyes of 13 patients) were retrospectively reviewed. Patient background, the severity of ROP, and the percentage of cases in which ROP regressed without additional treatment were compared between the two groups.

Results: Patient background and ROP severity were not significantly different between the two groups. Recurrence was observed in one eye of one patient in the IVB group, and thirteen eyes in seven patients in the IVR group required additional laser photocoagulation, which was significantly different in the two groups (p < 0.01, Fisher's exact test). In the IVR group, two eyes of two patients underwent vitreous surgery.

Conclusion: Compared with IVR, IVB is likely to control the severity of ROP with a single treatment.

Keywords: bevacizumab; ranibizumab; retinopathy of prematurity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Ozen Tunay Z., Ustunyurt Z., Idil A. Causes of severe visual impairment in infants and methods of management. Eye. 2021;35:1191–1197. doi: 10.1038/s41433-020-1101-z. - DOI - PMC - PubMed
    1. Hong E.H., Shin Y.U., Bae G.H., Choi Y.J., Ahn S.J., Sobrin L., Hong R., Kim I., Cho H. Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data. Sci. Rep. 2021;11:1451. doi: 10.1038/s41598-021-80989-z. - DOI - PMC - PubMed
    1. Ludwig C.A., Chen T.A., Hernandez-Boussard T., Moshfeghi A.A., Moshfeghi D.M. The epidemiology of retinopathy of prematurity in the United States. Ophthalmic Surg. Lasers Imaging Retin. 2017;48:553–562. doi: 10.3928/23258160-20170630-06. - DOI - PubMed
    1. Kim S.J., Port A.D., Swan R., Campbell J.P., Chan R.V.P., Chiang M.F. Retinopathy of prematurity; a review of risk factors and their clinical significance. Surv. Ophthalmol. 2018;63:618–637. doi: 10.1016/j.survophthal.2018.04.002. - DOI - PMC - PubMed
    1. Repka M.X., Palmer E.A., Tung B. Involution of retinopathy of prematurity. Cryotherapy for retinopathy of prematurity cooperative group. Arch. Ophthalmol. 2000;118:645–649. doi: 10.1001/archopht.118.5.645. - DOI - PubMed

LinkOut - more resources